None listed
Conditions
Interventions
Intervention1: ? Depigmentation Cream: 0.5 g - 0.75 g approx of product and apply on face and neck areas. Massage gently with fingertips in circular motion for 30 ? 60 seconds.
Twice a day applicatio
Sponsors
AMRA Remedies
Eligibility
Inclusion criteria
Inclusion criteria: 1. Voluntary women. 2. Between 18 and 45 years. 3. Photo type IV and below. 4. Presenting healthy skin on face. 5. Accepting not to use products with the same end benefit or containing sunscreen during the entire study duration. 6. Willing to avoid unusual sun exposure as far as possible for the entire study duration. 7. For whom the Investigator considers that the compliance will be correct. 8. Cooperating, informed of the need and duration of the examinations, and ready to comply with protocol procedures. 9. Having signed a Consent Form and will be once informed orally and in writing of all information concerning the study procedures and study objectives.
Exclusion criteria
Exclusion criteria: 1. Pregnant women and lactating women or women planning pregnancy. 2. Skin allergy antecedents or atopic subject. 3. Hypersensitivity to any cosmetic product, raw material. 4. Any clinically significant systemic or cutaneous disease, which may interfere with study treatments or procedures. 5. Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month). 6. Subject in an exclusion period or already participating in another similar cosmetic or therapeutic trial as identified during screening on visit 1 (V1).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Luminescence value and ITA value-Day 0, Day 30 and Day 60. Self evaluation questionnaire- Day 30 and Day 60.Timepoint: Luminescence value and ITA value-Day 0, Day 30 and Day 60. Self evaluation questionnaire- Day 30 and Day 60. | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Dermatological evaluation for skin tolerance at Visit 2 (Day 30) and Visit 3 (Day 60)Timepoint: â?¢ Dermatological evaluation for skin tolerance at Visit 2 (Day 30) and Visit 3 (Day 60) | — |
Countries
India
Contacts
Public ContactMrsTulip Bhattacharjee
C.L.A.I.M.S. Pvt. Ltd.
Outcome results
None listed